Lung cancer
PG1 Postgraduate Course
Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Clinical
Registration for this session is additional to the congress registration fee and is €268 on site, €244 standard
Aims : Access educational materials here
To highlight the most recent advances in diagnostics and therapy which every chest physician should be aware of when piloting and tailoring personalised care for lung cancer patients in a multi-professional setting; to provide an overview of the rapidly evolving lung cancer care with the goal of chronifying a so far almost devastating disease.
Target audience :
Allied health professional, Clinician, Emergency medicine doctor, Fellow, General practitioner, Immunologist, Intensivist/critical care physician, Junior member, Lung function technician, Nurse, Oncologist, Pathologist, Patient, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee, Pharmaceutical industry representative
09:30
Can lung cancer become a chronic disease? An update in lung cancer biology
S. Janes(London, United Kingdom)
COI
1
74
10:00
The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
T. Blum(Berlin, Germany)
COI
2
75
10:30
Group assignment
3
76
11:30
Non-invasive diagnostics: modern measures for screening and diagnosis
D. Baldwin(Nottingham (Nottinghamshire), United Kingdom)
COI
5
78
12:00
Invasive diagnostics and endoscopic interventions: the chest physician’s arsenal
A. Rozman(Golnik, Slovenia)
COI
6
79
12:30
Group assignment
7
80
14:00
From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
J. van Meerbeeck(Edegem (Antwerp), Belgium)
COI
9
82
14:30
Fitness for radical treatment modalities: efficient functional assessment, improving fitness and fitness-adapted therapy concepts including the elderly
M. Evison(Manchester, United Kingdom)
COI
10
83
15:00
Group assignment
11
84
16:00
Pathology meets clinic: translating lung cancer pathology into personalised care
F. Galateau-Salle(Lyon, France)
COI
13
86
16:30
Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies
T. Berghmans(Bruxelles, Belgium)
COI
14
87
17:00
Group assignment
15
88
. . .
